Fetal Vascular Hemodynamic Changes in Iron Deficiency Anemia
NCT ID: NCT03883841
Last Updated: 2019-03-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2019-05-31
2020-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intravenous Iron for Iron-deficiency Anemia in Pregnancy: a Randomized Controlled Trial
NCT03438227
Serum Ferritin Concentration and Fetal MCA Doppler as Predictors for Preterm Delivery
NCT02420743
The Oral Iron on the Prevention of Iron Deficiency Anemia in Obese Pregnant
NCT04101461
The Effect of Iron Deficiency Anemia During Pregnancy
NCT02590224
The Effect of Maternal Iron Deficiency Anemia on Fetal Hemodynamic and Neonatal Outcome
NCT04016922
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study group
patients with iron deficiency anemia
Iron Sucrose Solution for Injection
intravenous infusion of iron sucrose
control group
normal pregnant patients
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Iron Sucrose Solution for Injection
intravenous infusion of iron sucrose
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* singleton pregnancy
* iron deficiency anemia.
Exclusion Criteria
* antepartum hemorrhage
* major congenital fetal anomalies
* any other type of anemia other than iron deficiency anemia
* any acute or chronic maternal disease other than iron deficiency anemia.
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Mohamed Abbas
Principal investigator
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DIDA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.